Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience. (Q64973611)
Jump to navigation
Jump to search
scientific article published in September 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience. |
scientific article published in September 2001 |
Statements
Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience. (English)
1 reference
Recker F
1 reference
Kwiatkowski MK
1 reference
Huber A
1 reference
Stamm B
1 reference
Lehmann K
1 reference
Tscholl R
1 reference
1 September 2001
1 reference
166
1 reference
3
1 reference
851-855
1 reference
Identifiers
1 reference